We are live on ! Find out more
BC

Bartlett & Co Portfolio holdings

AUM $6.16B
1-Year Est. Return 20.29%
This Fund
S&P 500
This Quarter Est. Return
+6.08%
1 Year Est. Return
+20.29%
3 Year Est. Return
+30.84%
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$5.78B
AUM Growth
+$604M
Cap. Flow
+$315M
Cap. Flow %
5.44%
Top 10 Hldgs %
30.92%
Holding
1,221
New
145
Increased
296
Reduced
158
Closed
48

Top Buys

Rank Stock Value
1
CVX icon
Chevron
CVX
+$21.8M
2
AAPL icon
Apple
AAPL
+$17.5M
3
UNH icon
UnitedHealth
UNH
+$13.1M
4
TMO icon
Thermo Fisher Scientific
TMO
+$12.6M
5
CFR icon
Cullen/Frost Bankers
CFR
+$12.2M

Top Sells

Rank Stock Value
1
BMY icon
Bristol-Myers Squibb
BMY
+$18.1M
2
VCIT icon
Vanguard Intermediate-Term Corporate Bond ETF
VCIT
+$4.79M
3
USB icon
US Bancorp
USB
+$4.28M
4
CMCSA icon
Comcast
CMCSA
+$4.22M
5
TROW icon
T. Rowe Price
TROW
+$4.17M

Sector Composition

Rank Sector Weight
1 Technology 19.66%
2 Miscellaneous 17.21%
3 Healthcare 12.66%
4 Financials 11.11%
5 Industrials 9.32%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
BTI icon
626
British American Tobacco
BTI
$118B
$60K ﹤0.01%
1,800
+1,791
+19,900% +$61.2K
KNF icon
627
Knife River
KNF
$3.33B
$60K ﹤0.01%
+1,375
New +$58.3K
SUI icon
628
Sun Communities
SUI
$14.2B
$60K ﹤0.01%
461
– –
AVA icon
629
Avista
AVA
$3.13B
$59K ﹤0.01%
1,500
– –
BOX icon
630
Box
BOX
$4.69B
$59K ﹤0.01%
2,000
– –
CLF icon
631
Cleveland-Cliffs
CLF
$6.9B
$59K ﹤0.01%
+3,500
New +$55.5K
EBF icon
632
Ennis
EBF
$536M
$59K ﹤0.01%
2,871
– –
IBDS icon
633
iShares iBonds Dec 2027 Term Corporate ETF
IBDS
$3.92B
$59K ﹤0.01%
+2,500
New +$59.2K
NEA icon
634
Nuveen AMT-Free Quality Municipal Income Fund
NEA
$3.3B
$59K ﹤0.01%
5,356
+3,900
+268% +$42.7K
RVTY icon
635
Revvity
RVTY
$13.9B
$59K ﹤0.01%
493
– –
BAM icon
636
Brookfield Asset Management
BAM
$76.3B
$58K ﹤0.01%
1,777
– –
AZN icon
637
AstraZeneca
AZN
$244B
$57K ﹤0.01%
396
+84
+27% +$12.4K
CHWY icon
638
Chewy
CHWY
$8.61B
$57K ﹤0.01%
1,451
+1,301
+867% +$45.3K
MNST icon
639
Monster Beverage
MNST
$83.5B
$57K ﹤0.01%
2,000
– –
CACC icon
640
Credit Acceptance
CACC
$6.23B
$56K ﹤0.01%
110
– –
CEG icon
641
Constellation Energy
CEG
$104B
$56K ﹤0.01%
607
– –
CHDN icon
642
Churchill Downs
CHDN
$5.82B
$56K ﹤0.01%
+400
New +$54.7K
GSK icon
643
GSK
GSK
$97.8B
$56K ﹤0.01%
1,559
– –
IBDR icon
644
iShares iBonds Dec 2026 Term Corporate ETF
IBDR
$3.28B
$56K ﹤0.01%
+2,402
New +$56.7K
SPHQ icon
645
Invesco S&P 500 Quality ETF
SPHQ
$18.7B
$56K ﹤0.01%
+1,102
New +$53.1K
TSI
646
TCW Strategic Income Fund
TSI
$278M
$56K ﹤0.01%
12,000
+5,000
+71% +$23.4K
VOOG icon
647
Vanguard S&P 500 Growth ETF
VOOG
$27B
$55K ﹤0.01%
1,284
– –
VVV icon
648
Valvoline
VVV
$3.88B
$55K ﹤0.01%
+1,479
New +$53.7K
WRK
649
DELISTED
WestRock Company
WRK
$55K ﹤0.01%
1,890
– –
MRNA icon
650
Moderna
MRNA
$54.8B
$52K ﹤0.01%
430
+50
+13% +$6.67K
24 25
26
27 28

Similar funds

WMSA
Weiss Multi-Strategy Advisers New York $4.16B AUM 30.77% 1-Year Est. Return
SS
Simplicity Solutions Minneapolis, Minnesota $3.66B AUM 23.51% 1-Year Est. Return
PMEF
Point72 Middle East FZE Dubai, United Arab Emirates $3.38B AUM 14.09% 1-Year Est. Return
CC
Cannell & Co New York $3.15B AUM 30.62% 1-Year Est. Return
GW
GW & Wade Wellesley, Massachusetts $3.08B AUM 18.99% 1-Year Est. Return
GC
Greenlight Capital New York $2.05B AUM 78.75% 1-Year Est. Return
WP
WealthSource Partners San Luis Obispo, California $1.54B AUM 16.68% 1-Year Est. Return
BWM
Baystate Wealth Management Boston, Massachusetts $1.36B AUM 15.87% 1-Year Est. Return

Bartlett & Co's Q2 2023 Portfolio in Review

As of Q2 2023, Bartlett & Co held 1,221 positions worth $5.78B, up 12% from $5.18B the previous quarter. Its ten largest holdings account for 31% of the portfolio.

Bartlett & Co deployed $315M of net new capital in Q2 2023, opening 145 new positions and adding to 296 existing holdings. Its largest new stake was Toro Company: 25,480 shares worth $2.6M.

By sector, the portfolio is most concentrated in Technology at 20% of assets, up from 19% a quarter earlier, followed by Miscellaneous and Healthcare.

On the sell side, the largest reduction was Bristol-Myers Squibb, an estimated $18.1M trimmed.

  • Bartlett & Co's largest Q2 2023 buy was Toro Company: 25,480 shares worth $2.6M.
  • Bartlett & Co added most to Chevron in Q2 2023, an estimated $21.8M increase.
  • Bartlett & Co's biggest Q2 2023 reduction was Bristol-Myers Squibb, cutting an estimated $18.1M.
  • Bartlett & Co fully exited iPath Pure Beta Broad Commodity ETN in Q2 2023, selling an estimated $684K.
  • Bartlett & Co's ten largest holdings make up 31% of its $5.78B portfolio in Q2 2023.
  • Bartlett & Co opened 145 new positions and closed 48 in Q2 2023.
  • Bartlett & Co's portfolio value rose 12% quarter-over-quarter to $5.78B.

Based on Bartlett & Co's 13F filing for Q2 2023, filed 14 Jul 2023.